The journal The Lancet Infectious Diseases published a publication about the emergence of drug-resistant malaria parasites in a number of Southeast Asian countries. The malaria parasite is known resistant to artemisinin and piperaquine become a major drug in the treatment of malaria.
"Treatment of artemisinin and piperaquine does not show results. This is a serious threat to countries in Southeast Asia and may spread to other areas," said the researcher, as quoted by Reuters on Friday (01/08/2015).
 |
| Immune Malaria Drugs Emerging in Cambodia and Thailand |
Artemisinin resistance was found in five countries, namely Cambodia, Laos, Myanmar, Thailand and Vietnam. While resistance to artemisinin plus other drugs appear only Cambodia and Thailand, into two countries have the greatest risk of casualties.
Researchers worry if this incident is not immediately addressed, the transmission can be up to the regions of West Africa, where 90 percent of the world's malaria cases originate. With the knowledge of the public health system and worse, drug-resistant malaria could be the cause of the most recent deaths in the area.
The World Health Organization (WHO) calls approximately 3.2 billion people threatened by this disease. This number is very large, almost half of the Earth's population, and could become epidemic if no immediate action.
Earlier in a report in the journal Emerging Infectious Disease, Kimberly Fornance from the London School of Hygiene and Tropical Medicine pointed to a change in land use is a key factor in the increasing cases of human P. knowlesi.
Is a kind of parasite Plasmodium knowlesi malaria, during which only attacks the macaque monkey inhabitants of tropical forests. Later, the parasite was reported to attack humans.
With the increasingly widespread deforestation, the parasite is now one type of malaria most commonly found in Malaysia, and has been reported from various parts of Southeast Asia.
0 Response to " Immune Malaria Drugs Emerging in Cambodia and Thailand "
Post a Comment